Efficacy of Eye Movement Desensitization & Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan
Launched by KHUSHAL KHAN KHATTAK UNIVERISTY, KARAK, PAKISTAN · May 23, 2024
Trial Information
Current as of February 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how effective two different therapies are for treating Post-Traumatic Stress Disorder (PTSD), along with related issues like depression and anxiety. The therapies being compared are Eye Movement Desensitization and Reprocessing (EMDR) and Cognitive Behavioral Therapy (CBT). The goal is to see which method works better for people dealing with these mental health challenges in Pakistan.
To participate in this study, individuals need to be between the ages of 15 and 60 and have been diagnosed with PTSD as their main concern. Unfortunately, those who cannot move their hands or eyes, are unconscious for long periods, or have severe intellectual disabilities will not be eligible. Participants will receive either EMDR or CBT and will be monitored throughout the trial to assess how well each therapy helps them manage their symptoms. This study is currently looking for volunteers who meet the criteria and want to contribute to understanding better treatment options for PTSD.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • reverse of the exclusion critera
- Exclusion Criteria:
- The following patients will be excluded:
- • 1. Patients below the age of 15 years and above 60 years, since this study is neither on children nor on old aged patients;
- • 2. Patients who can't move their hands and eyes/or can't perform basic movements;
- • 3. Patients who are unconscious for longer periods and unable to recover consciousness;
- • 4. Patients not meeting the basic screening criteria of PTSD/ PTSD is not the main problem;
- • 5. Patients with severe intellectual impairments, since such patients are difficult to communicate
About Khushal Khan Khattak Univeristy, Karak, Pakistan
Khushal Khan Khattak University, located in Karak, Pakistan, is a distinguished educational institution committed to advancing research and innovation in various fields, including health sciences. The university is dedicated to fostering academic excellence and interdisciplinary collaboration, aiming to contribute to the improvement of public health outcomes through rigorous clinical trials and research initiatives. With a focus on ethical standards and scientific integrity, Khushal Khan Khattak University engages in clinical research that addresses critical health challenges, ultimately striving to enhance the well-being of communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karak, , Pakistan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0